Alerts will be sent to your verified email
Verify Email
TLL
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Trident Lifeline Limited is a pharmaceutical company that focuses on ethical marketing of a variety of products domestically and internationally through a third-party network spanning multiple countries around the world.
Trident Lifeline major competitors are Medico Remedies, Kimia Biosciences, Ambalal Sarabhai Ent, Gennex Lab, Balaxi Pharma., Fredun Pharma, Lyka Labs.
Market Cap of Trident Lifeline is ₹330 Crs.
While the median market cap of its peers are ₹345 Crs.
Trident Lifeline seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | ||||||||||||||||||
| Investor Presentation | Mar Jun Sep | Mar Jun Sep | Dec | |||||||||||||||
| Conference Call | ||||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
